Scarlet Formulation Private Limited
About Scarlet Formulation Private Limited
Data last updated:
Scarlet Formulation Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the hospital and clinical services segment of the healthcare sector. It was incorporated on 05 November 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ2008PTC027686. Its GSTIN is 08AAMCS5130Q1ZQ (Rajasthan). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Kushal Pal Singh and Anil Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 62 Panchsheel Enclave Behind Hotel Clark Jln Marg, Jaipur, Rajasthan, India – 302017.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.85 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹9.33 Lakh (net margin 1.4%) and EBITDA of ₹29.54 Lakh (EBITDA margin 4.3%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 1% over five years.
As per MCA filings, the company has open charges of ₹1.73 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address62 Panchsheel Enclave Behind Hotel Clark Jln Marg, Jaipur, Rajasthan, India – 302017
- IndustryHealthcare, Hospitals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Scarlet Formulation Private Limited
The main business activity of Scarlet Formulation is hospital and medical care. In detail, this covers hospital activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Scarlet Formulation Private Limited FY 2025 filings available
Scarlet Formulation Private Limited reported revenue of ₹6.85 Cr (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Scarlet Formulation Private Limited
Revenue rose 10% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA fell 64% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Scarlet Formulation Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹29.54 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹9.33 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Scarlet Formulation Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Scarlet Formulation are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Scarlet Formulation Private Limited
Scarlet Formulation Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Multi Specialty Hospitals). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Swastik Clinic & Seva Sadan Private Limited | •••• | •••• | •••• | •••• | - | Kolkata, West Bengal, India |
| Sahayog Hospital and Research Centre Pvt Ltd | •••• | •••• | •••• | •••• | - | Guna, Madhya Pradesh, India |
| Sushma Hospital and Research Centre Private Limited | •••• | •••• | •••• | •••• | - | Uttar Pradesh, India |
| G L Hospital Private Limited | •••• | •••• | •••• | •••• | - | Karaikkal, Pondicherry, India |
| Shraddha Multispeciality Hospitals Private Limited | •••• | •••• | •••• | •••• | - | Bhayander, Maharashtra, India |
| Scarlet Formulation Private Limited this company | •••• | •••• | •••• | •••• | - | Jaipur, Rajasthan, India |
| Abv Multispeciality Hospital Private Limited | •••• | •••• | •••• | •••• | - | Faroqnagar, Telangana, India |
| Megacity Nursing Home Private Limited | •••• | •••• | •••• | •••• | 15 | Kolkata, West Bengal, India |
| Livewell Health Care Private Limited | •••• | •••• | •••• | •••• | - | Hyderabad, Telangana, India |
| Southzone Hospitals and Research Centre Private Limited | •••• | •••• | •••• | •••• | - | Kunamkulam, Kerala, India |
| Ravi Medical and Research Centre Private Limited | •••• | •••• | •••• | •••• | - | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Scarlet Formulation by revenue in the Healthcare industry (Multi Specialty Hospitals), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of Scarlet Formulation Private Limited
Scarlet Formulation Private Limited is audited by JAIN CHOWDHARY & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| JAIN CHOWDHARY & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Scarlet Formulation Private Limited
Scarlet Formulation has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kushal Pal Singh Also directs: Devdhara Hospitalities Private Limited | Director | 25 Nov 2024 | 1 Years 10 Months | Current |
| Anil Kumar Also directs: Almo Impex (India) Private Limited, Almo Exports Private Limited, Anekant Pharmaceuticals Private Limited and 5 more | Director | 19 Oct 2024 | 1 Years 11 Months | Current |
| Ashwani Kumar Bhatia Also directs: Ruchi Pharma Distributors Private Limited, Medcart Anteka Private Limited, Mahip Hospitals Private Limited and 5 more | Director | 19 Oct 2024 | 1 Years 11 Months | Current |
Ownership and Shareholding of Scarlet Formulation Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Scarlet Formulation Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jan 2020 | Hdfc Bank Limited | ₹1 Cr | Open |
| 31 Oct 2013 | India Infoline Finance Limited | ₹15 Lakh | Open |
| 30 Sep 2013 | India Infoline Finance Limited | ₹48.63 Lakh | Open |
| 30 Sep 2013 | India Infoline Finance Limited | ₹9.45 Lakh | Open |
Total charge records: 4 View all charges
Employees and EPFO Compliance at Scarlet Formulation Private Limited
Employment history and EPFO contributions of people linked to Scarlet Formulation.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Scarlet Formulation Private Limited
Scarlet Formulation Private Limited has 13 board changes on record since 2008: 8 appointments and 5 cessations. The latest: Kushal Pal Singh was appointed as Director on 25 Nov 2024.
8 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Scarlet Formulation Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Scarlet Formulation Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Scarlet Formulation Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Scarlet Formulation Private Limited
Scarlet Formulation has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAMCS5130Q1ZQ | Rajasthan | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Scarlet Formulation Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Scarlet Formulation Private Limited
Scarlet Formulation is an active private limited company based in Jaipur, Rajasthan, India. The company works in hospitals, within the healthcare industry. It was incorporated on 05 November 2008 (18+ years old) and is registered under CIN U24232RJ2008PTC027686.
Scarlet Formulation reported revenue of ₹6.85 Cr for FY 2025 (up 10% YoY).
Scarlet Formulation has 3 current directors:
- Kushal Pal Singh - Director
- Anil Kumar - Director
- Ashwani Kumar Bhatia - Director
Scarlet Formulation reported a net profit of ₹9.33 Lakh (net margin 1.4%) and EBITDA of ₹29.54 Lakh (EBITDA margin 4.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Scarlet Formulation is -1% over three years and -1% over five years. In the latest year (FY 2025) revenue rose 10%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Scarlet Formulation is 08AAMCS5130Q1ZQ, registered in Rajasthan. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Scarlet Formulation is U24232RJ2008PTC027686. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Scarlet Formulation was incorporated on 05 November 2008, making it 18+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Scarlet Formulation by revenue are Swastik Clinic & Seva Sadan Private Limited, Sahayog Hospital and Research Centre Pvt Ltd, Sushma Hospital and Research Centre Private Limited, G L Hospital Private Limited, Shraddha Multispeciality Hospitals Private Limited and 5 more, all in the Healthcare industry (Multi Specialty Hospitals).
Kushal Pal Singh was appointed as Director on 25 Nov 2024. Rama Singh ceased to be Director on 21 Oct 2024. Anil Kumar was appointed as Director on 19 Oct 2024. Scarlet Formulation has 13 board changes on record in total.
The registered office of Scarlet Formulation is at 62 Panchsheel Enclave Behind Hotel Clark Jln Marg, Jaipur, Rajasthan, India – 302017.